We at Taylor Wessing are passionate about Life Sciences. We recognise that success in this industry is about delivering superior treatments and diagnostic tools to enhance patient care.
This is why we have focused our firm’s capabilities to provide a holistic service to the IP-rich, heavily regulated industries such as Biotech, Pharma, Medical Devices and the investors in those sectors: to enable innovative companies to bring about needed advancements that benefit humankind.
What both emerging companies and investors particularly value about Taylor Wessing is our ability to spot connections and opportunities as well as to avoid risks across the life cycle of their businesses, from obtaining crucial investment funding, building robust partnering/licensing deals, protecting data and IP rights, supporting their growth as products are placed on the market, to realising successful M&A transactions and IPOs.
Wherever your company is in its stages of development, Taylor Wessing is the firm that will help propel your business to the next stage.
Life sciences and healthcare companies and investors focused on this market segment value our holistic advice. This includes transformative business transactions such as a strategic partnering collaboration, raising capital or completing a game-changing M&A transaction; contentious matters such as patent litigation and product liability issues; and provision of practical, commercial recommendations about how to best navigate the complex regulatory, competition and data protection requirements that protect the value of their businesses and promote their future growth prospects.
We focus on emerging technological fields of advanced therapies such as immuno-oncology, cell and gene therapy; tissue engineering and regenerative medicine; areas of convergence such as the increasing importance of the collection and protection of patient data; digital health; medtech; the use of AI and blockchain. We also advise on emerging client service and business models relating to personalised medicine and patient experience-driven healthcare provision.
Clients can count on our life sciences and healthcare team to help them to meet these challenges and to succeed with the next steps of their company’s evolution.